Check out your Company Bowl for anonymous work chats.
Paige announces first ever CE Mark for Deep Learning in Pathology
Paige announces first ever CE Mark for Deep Learning in Pathology
Paige is named as one of CB Insights most promising digital health startups In addition to listing Paige as one of their most promising startups, CB Insights highlights Paige as one of the leaders in the transformation of pathology through artificial intelligence.
150 Digital Healthcare Companies & Startups l CB Insights
The technology we are bringing to clinics around the world: the First Clinical-Grade Artificial Intelligence in Pathology Article Published in Nature Medicine Provides Further Scientific Evidence for Deployment of Computational Decision Support Systems to Improve Patient Care.
Researchers Report Milestone in Use of Artificial Intelligence in Pathology
Paige.AI Ramps Up Cancer Pathology Research Using NVIDIA Supercomputer With the help of NVIDIA technology, Paige.AI is able to train deep neural networks from hundreds of thousands of gigapixel images of whole slides.
Paige.AI Ramps Up Cancer Pathology Research Using NVIDIA DGX | NVIDIA Blog
Paige is happy to announce that we have been granted Breakthrough Device designation by the FDA for our pioneering clinical-grade AI in pathology! This is the first such designation for AI in cancer diagnosis to be publicly announced by any company. Please find our press release from today here: http://glassdoor.com/slink.htm?key=vMcYl
FDA Grants Breakthrough Designation to Paige.AI